132 related articles for article (PubMed ID: 36062762)
61. Radiomics signature based on computed tomography images for the preoperative prediction of lymph node metastasis at individual stations in gastric cancer: A multicenter study.
Sun Z; Jiang Y; Chen C; Zheng H; Huang W; Xu B; Tang W; Yuan Q; Zhou K; Liang X; Chen H; Han Z; Feng H; Yu S; Hu Y; Yu J; Zhou Z; Wang W; Xu Y; Li G
Radiother Oncol; 2021 Dec; 165():179-190. PubMed ID: 34774652
[TBL] [Abstract][Full Text] [Related]
62. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.
Li Z; Ma X; Shen F; Lu H; Xia Y; Lu J
BMC Med Imaging; 2021 Feb; 21(1):30. PubMed ID: 33593304
[TBL] [Abstract][Full Text] [Related]
63. The added value of radiomics from dual-energy spectral CT derived iodine-based material decomposition images in predicting histological grade of gastric cancer.
Shi C; Yu Y; Yan J; Hu C
BMC Med Imaging; 2022 Oct; 22(1):173. PubMed ID: 36192686
[TBL] [Abstract][Full Text] [Related]
64. Preoperative prediction for lauren type of gastric cancer: A radiomics nomogram analysis based on CT images and clinical features.
Sun Z; Jin L; Zhang S; Duan S; Xing W; Hu S
J Xray Sci Technol; 2021; 29(4):675-686. PubMed ID: 34024809
[TBL] [Abstract][Full Text] [Related]
65. A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
Liu S; Du S; Gao S; Teng Y; Jin F; Zhang L
BMC Cancer; 2023 Jan; 23(1):15. PubMed ID: 36604679
[TBL] [Abstract][Full Text] [Related]
66. Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study.
Xie K; Cui Y; Zhang D; He W; He Y; Gao D; Zhang Z; Dong X; Yang G; Dai Y; Li Z
Front Oncol; 2021; 11():770758. PubMed ID: 35070974
[TBL] [Abstract][Full Text] [Related]
67. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
68. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
[TBL] [Abstract][Full Text] [Related]
69. Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy.
Tang X; He Q; Qu H; Sun G; Liu J; Gao L; Shi J; Ye J; Liang Y
BMC Cancer; 2019 Aug; 19(1):797. PubMed ID: 31409315
[TBL] [Abstract][Full Text] [Related]
70. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
[TBL] [Abstract][Full Text] [Related]
71. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E
Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558
[TBL] [Abstract][Full Text] [Related]
72. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
Lombardi PM; Mazzola M; Achilli P; Aquilano MC; De Martini P; Curaba A; Gualtierotti M; Bertoglio CL; Magistro C; Ferrari G
J Surg Oncol; 2021 Mar; 123(4):923-931. PubMed ID: 33497471
[TBL] [Abstract][Full Text] [Related]
73. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication.
Wei J; Yang G; Hao X; Gu D; Tan Y; Wang X; Dong D; Zhang S; Wang L; Zhang H; Tian J
Eur Radiol; 2019 Feb; 29(2):877-888. PubMed ID: 30039219
[TBL] [Abstract][Full Text] [Related]
74. Radiomics-based model for predicting pathological complete response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
Choi SJ; Park KJ; Heo C; Park BW; Kim M; Kim JK
Clin Radiol; 2021 Aug; 76(8):627.e13-627.e21. PubMed ID: 33762138
[TBL] [Abstract][Full Text] [Related]
75. Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.
Li W; Zhang L; Tian C; Song H; Fang M; Hu C; Zang Y; Cao Y; Dai S; Wang F; Dong D; Wang R; Tian J
Eur Radiol; 2019 Jun; 29(6):3079-3089. PubMed ID: 30519931
[TBL] [Abstract][Full Text] [Related]
76. Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Li J; Yan LL; Zhang HK; Wang Y; Xu SN; Li HL; Qu JR
Abdom Radiol (NY); 2022 Oct; 47(10):3394-3405. PubMed ID: 35916943
[TBL] [Abstract][Full Text] [Related]
77. Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer.
Jeon SH; Song C; Chie EK; Kim B; Kim YH; Chang W; Lee YJ; Chung JH; Chung JB; Lee KW; Kang SB; Kim JS
Radiat Oncol; 2019 Mar; 14(1):43. PubMed ID: 30866965
[TBL] [Abstract][Full Text] [Related]
78. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
[TBL] [Abstract][Full Text] [Related]
79. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
80. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
Gu J; Tong T; Xu D; Cheng F; Fang C; He C; Wang J; Wang B; Yang X; Wang K; Tian J; Jiang T
Cancer; 2023 Feb; 129(3):356-366. PubMed ID: 36401611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
